Spectrum News: New study finds molecule to help treat asthma
UC researcher's battle with the condition as a child inspired research
For Satish Madala, MD, of the Division of Pulmonary, Critical Care and Sleep Medicine at the UC College of Medicine, his research into asthma treatments comes from personal experience, having been diagnosed with asthma as a child. He lead a just-published study that identifies a molecule that could lead to improved treatments for asthma.
In an interview with Spectrum News for a story on the study, Madala said, "Asthma usually attacks late in the night. It keeps you awake, it gives you sleepless nights."
Madala says this is because your immune system is trying to fight off allergens.
Satish Madala, PhD, in the Department of Pulmonary, Critical Care and Sleep Medicine at the UC College of Medicine/Photo/Andrew Higley/UC Marketing + Brand
"Your airways become narrow," said Madala. "When they become narrow, you can't take enough of the oxygen you need. So that's why kids cannot sleep, or even adults, when they have an asthma attack, they cannot breathe."
Matish lead a team of doctors and researchers at UC who collaborated with researchers at Cincinnati Children's on a study to help discover better treatment for asthma.
Through their study, they found that a protein called interleukin 31 receptor is what is needed to help people with asthma breathe easier. And now they’re looking to see what other elements are needed to make it effectively work for treatment.
Madala and his team are now trying to figure out what other elements are needed for the treatment to work effectively.
“We need to understand where that binding is happening,” said Madala. “So then we can develop a drug molecule that can prevent that interaction. So that so we can uncouple these interactions that drive that contractility. So then that molecule becomes a therapy for these patients.”
See the entire Spectrum story here.
Read more about Madala's research here.
Lead photo of Madala and graduate student Santhoshi Akkenapally/Andrew Higley/UC Marketing + Brand
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Colorado silica dust trial could change the way industry does business
May 17, 2026
Betsy Malloy, Andrew Katsanis Professor of Law, at the University of Cincinnati, spoke with Bloomberg Law about how a Colorado trial could change the way the stone fabrication industry does business.
Driven by curiosity, guided by care
May 14, 2026
Max Wilson, a University of Cincinnati College of Allied Health Sciences health sciences major on the pre-physician assistant track, found his path expanding beyond the classroom and into hands-on research focused on human performance and patient care.
New cohort of nursing students get ready to join co-ops
May 14, 2026
A new chapter is beginning for more than 100 University of Cincinnati College of Nursing rising seniors as they embark on one of the most distinctive experiences in undergraduate nursing education: the UC Nursing Co-op Program. The incoming cohort will fan out across Cincinnati's premier healthcare institutions, stepping into some of the most dynamic and specialized clinical environments in the region. Placement sites include UC Medical Center (UCMC), West Chester Hospital, Cincinnati Children's Hospital Medical Center (CCHMC) Burnet, College Hill, and Liberty campus.